Share of U.S. adults with age-related macular degeneration 2019, by stage & ethnicity

Percentage of U.S. adults with age-related macular degeneration (AMD) in 2019, by stage and race/ethnicity

Loading statistic...
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

2022

Region

United States

Survey time period

2019

Age group

40 years and older

Special properties

based on 2019 population estimates

Supplementary notes

According to the source, Age-related Macular Degeneration (AMD) can be defined as having vision threatening or non-vision threatening AMD. Vision-threatening AMD refers to late or advanced stages of the disease, including geographic atrophy and/or exudative AMD in either eye. Non-vision threatening AMD, or early stage AMD, includes retinal pigment epithelium abnormalities or drusen ≥125 µm in the worse-affected eye, but no vision threatening AMD in either eye.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,148 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD $179 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Vision problems in the U.S. "

Other statistics that may interest you Vision problems in the U.S.

Global overview

7

Vision disability in the U.S.

4

Age-related macular degeneration (AMD)

6

Diabetes and vision loss

5

Treatment market

5

Miscellaneous

6
Statista Accounts: Access All Statistics. Starting from $2,148 USD / Year
Learn more about how Statista can support your business.